These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4624843)

  • 1. [Regression of gout tophi under long-term therapy with allopurinol].
    Kröpelin T; Mertz DP
    Med Klin; 1972 Apr; 67(17):614-8. PubMed ID: 4624843
    [No Abstract]   [Full Text] [Related]  

  • 2. Withdrawal of longterm antihyperuricemic therapy in tophaceous gout.
    van Lieshout-Zuidema MF; Breedveld FC
    J Rheumatol; 1993 Aug; 20(8):1383-5. PubMed ID: 8230024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-negative dual-energy computed tomography in a patient with acute gout.
    Glazebrook KN; Kakar S; Ida CM; Laurini JA; Moder KG; Leng S
    J Clin Rheumatol; 2012 Apr; 18(3):138-41. PubMed ID: 22426590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathological symptoms in the Roentgen picture of small joints. Their origin and differential diagnosis].
    Walther W; Dickmann P; Brizle H
    Med Klin; 1971 Apr; 66(18):679-85. PubMed ID: 5574415
    [No Abstract]   [Full Text] [Related]  

  • 5. Allopurinol hypersensitivity in a patient with coexistent systemic lupus erythematosus and tophaceous gout.
    McDonald J; Fam AG; Paton T; Senn J
    J Rheumatol; 1988; 15(5):865-8. PubMed ID: 3172103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of daily single doses of 300 mg allopurinol on serum uric acid concentration and urate excretion in gouty patients (author's transl)].
    Matzkies F; Berg G
    Dtsch Med Wochenschr; 1974 Nov; 99(48):2464-5. PubMed ID: 4448143
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
    Li-Yu J; Clayburne G; Sieck M; Beutler A; Rull M; Eisner E; Schumacher HR
    J Rheumatol; 2001 Mar; 28(3):577-80. PubMed ID: 11296962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Osteoplastic reactions in chronic gout (author's transl)].
    Dihlmann W; Fernholz HJ
    Fortschr Geb Rontgenstr Nuklearmed; 1974 Feb; 120(2):216-8. PubMed ID: 4362985
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors associated with acute gout attacks in normouricaemic gout patients receiving allopurinol: a retrospective study.
    So MW; Lee SG; Kim YG; Lee CK; Yoo B
    Scand J Rheumatol; 2011 Nov; 40(6):444-7. PubMed ID: 21916803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout.
    Stocker SL; Graham GG; McLachlan AJ; Williams KM; Day RO
    J Rheumatol; 2011 May; 38(5):904-10. PubMed ID: 21285173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gout - a surgical problem].
    Flügel M; Geldmacher J
    Handchirurgie; 1978; 10(1):15-8. PubMed ID: 689495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for the formation of double-contour sign and tophi in gout.
    Sun C; Qi X; Tian Y; Gao L; Jin H; Guo H
    J Orthop Surg Res; 2019 Jul; 14(1):239. PubMed ID: 31358044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of endogenous uric acid synthesis with allopurinol in gout and urate diathesis. Remarks on E. Holländer and P. Schwarczmann, Münch. Med. Wschr. 3 (1969) 32, 1623-1626].
    Zöllner N
    Munch Med Wochenschr; 1970 Dec; 112(49):2263-4. PubMed ID: 5536821
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term use of allopurinol in the treatment of gout.
    Kersley GD
    Ann Rheum Dis; 1970 Jan; 29(1):89-92. PubMed ID: 5416104
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gout with giant tophi: description of a case].
    Buzzone G; Sambataro A; Camarda G; Castiglione F; Schillaci W; Balsamo S; Verde F
    Clin Ter; 1985 Oct; 115(2):123-6. PubMed ID: 4075754
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long lasting normalization of uric acid after combination therapy with 300 mg allopurinol and 60 mg benzbromarone in patients with gout and hyperuricemia].
    Matzkies F
    Med Klin (Munich); 1992 Sep; 87(9):460-2. PubMed ID: 1406482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allopurinol].
    Scott JT
    Schweiz Med Wochenschr; 1967 Dec; 97(49):1659-62. PubMed ID: 5596893
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chondrocalcinosis in gout].
    Siniachenko OV; Diadyk AI; Romanenko VN; Bukharovich MN; Protsenko TV; Khomenko MV
    Revmatologiia (Mosk); 1991; (3):28-30. PubMed ID: 1812558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events.
    Dalbeth N; Stamp L
    Semin Dial; 2007; 20(5):391-5. PubMed ID: 17897242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.